Inari Medical Inc Ordinary Shares NARI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NARI is a good fit for your portfolio.
News
-
Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice – Contact Johnson Fistel, LLP
-
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
-
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
-
Inari Medical, Inc. (NARI) Downgraded by Analysts Due to Pending DOJ Probe – Hagens Berman
-
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Inari Medical, Inc. and Encourages Investors with Losses to Contact the Firm
-
Inari Medical to Announce First Quarter 2024 Financial Results
-
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
-
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
Trading Information
- Previous Close Price
- $38.18
- Day Range
- $37.46–38.57
- 52-Week Range
- $36.73–71.85
- Bid/Ask
- $36.75 / $39.53
- Market Cap
- $2.21 Bil
- Volume/Avg
- 873,495 / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 409.01
- Price/Sales
- 4.38
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,300
- Website
- https://www.inarimedical.com
Comparables
Valuation
|
Metric
|
NARI
|
ANIK
|
TCMD
|
|---|---|---|---|
Price/Earnings (Normalized) | 409.01 | — | 26.22 |
Price/Book Value | 4.73 | 1.79 | 1.74 |
Price/Sales | 4.38 | 2.28 | 1.21 |
Price/Cash Flow | 64.92 | 36.73 | 15.97 |
Price/Earnings
NARI
ANIK
TCMD
Financial Strength
|
Metric
|
NARI
|
ANIK
|
TCMD
|
|---|---|---|---|
Quick Ratio | 2.43 | 3.50 | 2.88 |
Current Ratio | 3.09 | 5.26 | 3.54 |
Interest Coverage | −56.99 | — | — |
Quick Ratio
NARI
ANIK
TCMD
Profitability
|
Metric
|
NARI
|
ANIK
|
TCMD
|
|---|---|---|---|
Return on Assets (Normalized) | 5.07% | −1.35% | 10.70% |
Return on Equity (Normalized) | 6.37% | −1.65% | 18.16% |
Return on Invested Capital (Normalized) | 3.35% | −2.24% | 12.90% |
Return on Assets
NARI
ANIK
TCMD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Bpscpgck | Rmftgrq | $185.4 Bil | |
SYK
| Stryker Corp | Ccbxhplqk | Sktrg | $128.2 Bil | |
BSX
| Boston Scientific Corp | Bzgmxjc | Bpcgkjp | $107.7 Bil | |
MDT
| Medtronic PLC | Nmqptkky | Yjjvfm | $105.2 Bil | |
DXCM
| DexCom Inc | Yrnlmqqnf | Tplwf | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Jmlcjlkrk | Dqwvh | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Jmnsntxff | Bznzv | $24.6 Bil | |
ALGN
| Align Technology Inc | Xkmvsbyf | Gcjqqm | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Wtkgkpmd | Lkcrhl | $18.7 Bil | |
PODD
| Insulet Corp | Tsmygkzj | Fhzdbp | $11.5 Bil |